[HTML] frontiersin.org

[HTML][HTML] Microbiota and lung cancer. opportunities and challenges for improving immunotherapy efficacy

M Ocáriz-Díez, M Cruellas, M Gascón, R Lastra… - Frontiers in …, 2020 - frontiersin.org
The advances in molecular biology and the emergence of Next Generation Sequencing
(NGS) have revealed that microbiome composition is closely related with health and …
被引用次数：26 相关文章
[HTML] nih.gov

[HTML][HTML] Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

M Ocáriz-Díez, M Cruellas, M Gascón… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
The advances in molecular biology and the emergence of Next Generation Sequencing
(NGS) have revealed that microbiome composition is closely related with health and …

Microbiota and lung cancer. Opportunities and challenges for improving immunotherapy efficacy

M Ocáriz, M Cruellas, M Gascón, R Lastra… - 2020 - digital.csic.es
The advances in molecular biology and the emergence of Next Generation Sequencing
(NGS) have revealed that microbiome composition is closely related with health and …
[PDF] academia.edu

[PDF][PDF] Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

M Ocáriz-Díez, M Cruellas, M Gascón, R Lastra… - academia.edu
The advances in molecular biology and the emergence of Next Generation Sequencing
(NGS) have revealed that microbiome composition is closely related with health and …

[引用][C] Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

M Ocáriz-Díez, M Cruellas, M Gascón, R Lastra… - Frontiers in …, 2020 - cir.nii.ac.jp
Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy
Efficacy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

M Ocáriz-Díez, D Isla, EM Gálvez… - Front. oncol …, 2020 - zaguan.unizar.es
The advances in molecular biology and the emergence of Next Generation Sequencing
(NGS) have revealed that microbiome composition is closely related with health and …

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

M Ocáriz-Díez, M Cruellas, M Gascón… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
The advances in molecular biology and the emergence of Next Generation Sequencing
(NGS) have revealed that microbiome composition is closely related with health and …

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy.

M Ocáriz-Díez, M Cruellas, M Gascón, R Lastra… - Frontiers in …, 2020 - europepmc.org
The advances in molecular biology and the emergence of Next Generation Sequencing
(NGS) have revealed that microbiome composition is closely related with health and …
[PDF] unizar.es

[PDF][PDF] Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

M Ocáriz-Díez, M Cruellas, M Gascón, R Lastra… - zaguan.unizar.es
The advances in molecular biology and the emergence of Next Generation Sequencing
(NGS) have revealed that microbiome composition is closely related with health and …

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy.

M Ocáriz-Díez, M Cruellas, M Gascón, R Lastra… - Frontiers in …, 2020 - europepmc.org
The advances in molecular biology and the emergence of Next Generation Sequencing
(NGS) have revealed that microbiome composition is closely related with health and …